(Q52236819)

English

MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference.

scientific article published in June 1991

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

title

MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

0 references

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

author name string

Reid LD

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

language of work or name

English

0 references

publication date

1 June 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

published in

Pharmacology, Biochemistry and Behavior

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

volume

39

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

page(s)

509-512

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

Identifiers

DOI

10.1016/0091-3057(91)90217-P

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

PubMed publication ID

1682951

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1682951

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1682951

ResearchGate publication ID

21472715

0 references

(Q52236819)

MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)